iShares NASDAQ Biotechnology Index (IBB) gets attention
Kevin Depew, executive editor at Minyanville.com brought the spotlight on iShares NASDAQ Biotechnology Index (ETF) (AMEX:IBB) yesterday. Shares of IBB are up 3% since Tuesday and trade at $83, so let's take a further look.
Kangas: OK. What areas are you looking for, for good upside potential?
Depew: Well, Paul, we're getting close to the time when there is a seasonal move in biotech. It started a little bit earlier this year than usual. Normally, it's in August. But I think part of the rotation away from financials, the longer-term rotation away from energy stocks that have performed so well, some of that demand is creeping into biotech now.
Kangas: Well, to that point, are there some specific stocks that you're keeping an eye on in the biotech sector?
Article Contined Below Ad
Depew: Yes, the easiest way to play it is I think with the iShares Nasdaq Biotech Index ETF, the symbol is IBB. I do own shares in that, by the way. I think that's the easiest way to play it. I'm not crazy about they're weighting in Amgen (AMGN), but there are some other components there that I do like.
Kangas: OK, how about another choice?
Depew: The other one in there that's in that ETF is Biomarin. The symbol is BMRN. I think that that's another way to play it. And the third way would be with Genzyme, symbol GENZ.
Kangas: Let's have a chart on that. And we see it's been getting strong recently.
Depew: That's right. There is some demand creeping in. They are ahead of the seasonal patterns, and I think that that usually is a nice run up until the fall.
Kangas: OK. Now you said you own the ETF. How about Biomarin and Genzyme? Are you personally an owner of those two stocks?
Depew: No, just through the ETF, Paul.
Kangas: So biotech is your favorite in this market.
Depew: Biotech, and for the retail investor at home, you just have to stay away from financials for now.
Here's the downlow on the IBB, click on the link to visit the source at ishares.com :
| Top Holdings *(Daily) as of 7/16/2008 | |
|---|---|
| View All Holdings | |
| 10.03% | AMGEN INC |
| 9.86% | GILEAD SCIENCES INC |
| 7.69% | CELGENE CORP |
| 5.10% | TEVA PHARMACEUTICAL-S P ADR |
| 4.14% | GENZYME CORP |
| 4.00% | BIOGEN IDEC INC |
| 2.49% | VERTEX PHARMACEUTICALS INC |
| 2.44% | ILLUMINA INC |
| 2.08% | BIOMARIN PHARMACEUTICAL INC |
| 1.89% | PERRIGO CO |
*Holdings are subject to change.
| Top Sectors as of 7/16/2008 | |
|---|---|
| 58.23% | Medical-Biomedical / Gene |
| 14.05% | Medical-Drugs |
| 13.83% | Therapeutics |
| 6.99% | Medical-Generic Drugs |
| 1.46% | Medical Instruments |
| 1.43% | Diagnostic Equipment |
| 1.42% | Drug Delivery Systems |
| 1.31% | Diagnostic Kits |
| 0.62% | Medical Products |
| 0.31% | Research & Development |
At this point Masters, looking to get into a sector early is a great play, so add the IBB to your watch list.
Best of the Blogs

BlogDroid 600
Scanning and identifying the best blog entries every hour
- Anonymous Hacks, Records Conference Call Between FBI And Scotland Yard | ZeroHedge
- News That Matters | ZeroHedge
- We All Await The Highly Anticipated Sell-Off | iBankCoin.com
- Outlook & Investment Strategy: Three Themes for 2012 | Financial Sense
- Stock #Market Recap 02/02/12 {Video} | iBankCoin.com
- The Most Important Resource for Our Future: Inexpensive Oil | Financial Sense
- Gold Breaks Bearish Trendline; Key Target for Silver at $37 | Financial Sense
Latest Headlines

Newsbot 3000
The most relevant financial news and articles from the Internets
- SHOCKING UPSET: Bloomberg TV Has Hotter Female... | Business Insider
- Here Are 3 Ideas That Will Help Fix The Housing Market | Business Insider
- Nicolas Sarkozy Bussed In Construction Workers To A Media Event To Make Himself Look... | Business Insider
- Top Investment Gurus Sound Off On The Facebook IPO | Business Insider
- Wait, Charlie Sheen's New TV Show Actually Sounds Kind... | Business Insider
- Facebook IPO: It's All About the Ads | TheStreet.com
- Notable Merger and Acquisition of the... | StreetInsider.com



Post new comment